Burnier M - Search Results

1

Association between white-coat effect and blunted dipping of nocturnal blood pressure.

Bochud M, Bovet P, Vollenweider P, Maillard M, Paccaud F, Wandeler G, Gabriel A, Burnier M. Bochud M, et al. Among authors: burnier m. Am J Hypertens. 2009 Oct;22(10):1054-61. doi: 10.1038/ajh.2009.133. Epub 2009 Jul 23. Am J Hypertens. 2009. PMID: 19629048

2

Use of non-invasive ambulatory blood pressure monitoring to screen for high-risk hypertensive patients.

Christen Y, Ganslmayer M, Waeber B, Burnier M, Nussberger J, Brunner HR. Christen Y, et al. Among authors: burnier m. J Hypertens Suppl. 1990 Dec;8(6):S119-24. J Hypertens Suppl. 1990. PMID: 2081993

3

Ambulatory blood pressure measurement and antihypertensive therapy.

Waeber B, Burnier M, Perret F, Nussberger J, Brunner HR. Waeber B, et al. Among authors: burnier m. J Hypertens Suppl. 1989 May;7(3):S33-9. J Hypertens Suppl. 1989. PMID: 2668463 Clinical Trial.

4

Effects of smoking and physical exercise on platelet free cytosolic calcium in healthy normotensive volunteers.

Mooser V, Burnier M, Nussberger J, Juillerat L, Waeber B, Brunner HR. Mooser V, et al. Among authors: burnier m. J Hypertens. 1989 Mar;7(3):211-6. J Hypertens. 1989. PMID: 2708817

5

Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.

Favrat B, Burnier M, Nussberger J, Lecomte JM, Brouard R, Waeber B, Brunner HR. Favrat B, et al. Among authors: burnier m. J Hypertens. 1995 Jul;13(7):797-804. J Hypertens. 1995. PMID: 7594444 Clinical Trial.

6

Renal sodium handling in patients with untreated hypertension and white coat hypertension.

Burnier M, Biollaz J, Magnin JL, Bidlingmeyer M, Brunner HR. Burnier M, et al. Hypertension. 1994 Apr;23(4):496-502. doi: 10.1161/01.hyp.23.4.496. Hypertension. 1994. PMID: 8144219

7

Isolated office hypertension: a prehypertensive state?

Bidlingmeyer I, Burnier M, Bidlingmeyer M, Waeber B, Brunner HR. Bidlingmeyer I, et al. Among authors: burnier m. J Hypertens. 1996 Mar;14(3):327-332. doi: 10.1097/00004872-199603000-00009. J Hypertens. 1996. PMID: 8723986

8

Renal haemodynamic and protective effects of calcium antagonists in hypertension.

Zanchi A, Brunner HR, Waeber B, Burnier M. Zanchi A, et al. Among authors: burnier m. J Hypertens. 1995 Dec;13(12 Pt 1):1363-75. J Hypertens. 1995. PMID: 8866898 Review.

9

Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients.

Pechère-Bertschi A, Nussberger J, Decosterd L, Armagnac C, Sissmann J, Bouroudian M, Brunner HR, Burnier M. Pechère-Bertschi A, et al. Among authors: burnier m. J Hypertens. 1998 Mar;16(3):385-93. doi: 10.1097/00004872-199816030-00016. J Hypertens. 1998. PMID: 9557932 Clinical Trial.

10

Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists.

Mazzolai L, Maillard M, Rossat J, Nussberger J, Brunner HR, Burnier M. Mazzolai L, et al. Among authors: burnier m. Hypertension. 1999 Mar;33(3):850-5. doi: 10.1161/01.hyp.33.3.850. Hypertension. 1999. PMID: 10082498 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,168 results

Search Page

Filters